Today: 13 March 2026
Subscribe
Browse Category

NASDAQ:ABBV 30 January 2026 - 31 January 2026

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie shares rose 1.17% to $223.01 Friday, outperforming a broader market dip after Donald Trump nominated Kevin Warsh to lead the Federal Reserve. Trading volume in AbbVie topped its 50-day average ahead of next week’s earnings report. The stock remains about 9% below its 52-week high. AbbVie will release results and hold its earnings call early Wednesday.
31 January 2026
···
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
···

Stock Market Today

  • Credit Suisse High Yield Bond Fund (DHY) Ex-Dividend Date on March 16, 2026
    March 13, 2026, 10:55 AM EDT. Credit Suisse High Yield Bond Fund (DHY) will trade ex-dividend on March 16, 2026, with a monthly payment of $0.0155 per share, representing about 0.83% of its recent price of $1.87. The dividend is payable on March 23, 2026. DHY's annualized dividend yield currently stands near 9.96%. The fund's share price has fluctuated between $1.82 and $2.16 over the past year, closing at $1.86 recently. Market participants often see ex-dividend dates as signals that share prices will adjust downward by the dividend amount, all else equal. DHY shares were up 0.4% in recent trading, reflecting ongoing interest in monthly dividend-paying bond funds.
Go toTop